Hematopoietic Stem Cell Transplantations for Primary Immune Deficiencies: 3 Decades of Experience from a Tertiary Medical Center

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 5, 2015, Pages e295-e300

  Rousso, Sharon Z ^a,f   Shamriz, Oded ^b   Zilkha, Amir ^e   Braun, Jacques ^e   Averbuch, Diana ^a,b   Or, Reuven ^c   Weintraub, Michael ^d   Revel Vilk, Shoshana ^d   Stepensky, Polina ^d  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b Departments of Pediatrics   (Israel)

^c Departments of Bone Marrow Transplantation and Cancer Immunotherapy   (Israel)

^d Departments of Pediatric Hematology Oncology and Bone Marrow Transplantation   (Israel)

^e Children's Health Care of Atlanta at Egleston   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

bone marrow transplantation; hematopoietic stem cell transplantation; primary immune deficiency

Indexed keywords

CYCLOSPORIN A; FLUDARABINE; METHOTREXATE; MYCOPHENOLATE MOFETIL;

ACUTE GRAFT VERSUS HOST DISEASE; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRANULOCYTE DEFECT; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HUMAN; IMMUNE DEFICIENCY; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL RATE; SURVIVAL TIME; TERTIARY CARE CENTER; WISKOTT ALDRICH SYNDROME; CHILD, PRESCHOOL; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; METHODS; MORTALITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TRANSPLANTATION CONDITIONING;

CHILD; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; INFANT; INFANT, NEWBORN; KAPLAN-MEIER ESTIMATE; MALE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; TRANSPLANTATION CONDITIONING;

EID: 84940102294     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000352     Document Type: Article

References (21)

1. Parvaneh N, Casanova JL, Notarangelo LD, et al. Primary immunodeficiencies: a rapidly evolving story. J Allergy Clin Immunol. 2013;131:314-323.
2. Rao K, Amrolia PJ, Jones A, et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood. 2005;105:879-885.
3. Chiesa R, Veys P. Reduced-intensity conditioning for allogeneic stem cell transplant in primary immune deficiencies. Expert Rev Clin Immunol. 2012;8:255-266. quiz 267.
4. Slatter MA, Gennery AR. Advances in hematopoietic stem cell transplantation for primary immunodeficiency. Expert Rev Clin Immunol. 2013;9:991-999.
5. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18: 295-304.
6. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215-233.
7. Gatti RA, Meuwissen HJ, Allen HD, et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet. 1968;2:1366-1369.
8. Bach FH, Albertini RJ, Joo P, et al. Bone-marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet. 1968;2:1364-1366.
9. Stepensky P, Krauss A, Goldstein G, et al. Impact of conditioning on outcome of hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome. J Pediatr Hematol Oncol. 2013;35:e234-e238.
10. Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011;118:1675-1684.
11. Gennery AR, Slatter MA, Grandin L, et al. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126:602-610. e601-611.
12. Arnaout K, Patel N, Jain M, et al. Complications of allogeneic, hematopoietic stem cell transplantation. Cancer Invest. 2014;32: 349-362.
13. de la Morena MT, Nelson RP. Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review. Clin Rev Allergy Immunol. 2014;46:131-144.
14. Antoine C, Müller S, Cant A, et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet. 2003;361:553-560.
15. Grunebaum E, Roifman CM. Bone marrow transplantation using HLA-matched unrelated donors for patients suffering from severe combined immunodeficiency. Immunol Allergy Clin North Am. 2010;30:63-73.
16. Morio T, Atsuta Y, Tomizawa D, et al. Outcome of unrelated umbilical cord blood transplantation in 88 patients with primary immunodeficiency in Japan. Br J Haematol. 2011;154: 363-372.
17. Veys P. Reduced intensity transplantation for primary immunodeficiency disorders. Pediatr Rep. 2011;3(suppl 2):e11.
18. Marsh RA, Jordan MB, Filipovich AH. Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward. Br J Haematol. 2011;154:556-563.
19. Frangoul H, Wang L, Harrell FE, et al. Unrelated umbilical cord blood transplantation in children with immune deficiency: results of a multicenter study. Bone Marrow Transplant. 2010;45:283-288.
20. Stikvoort A, Gertow J, Sundin M, et al. Chimerism patterns of long-term stable mixed chimeras posthematopoietic stem cell transplantation in patients with nonmalignant diseases: followup of long-term stable mixed chimerism patients. Biol Blood Marrow Transplant. 2013;19:838-844.
21. Grunebaum E, Mazzolari E, Porta F, et al. Bone marrow transplantation for severe combined immune deficiency. JAMA. 2006;295:508-518.